Breast cancer has been proposed to be classified into several subtypes based on the expression profiles of ERα, PR, HER2, and Ki-67 LI, such as luminal A, luminal B, luminal B HER2, HER2-enriched, and triple negative (basal-like) [18, 19]. This evidence concerns the gene ESR1 and breast carcinoma.